The National Institute of Health and Care Excellence (NICE) has published new guidance for the month of October 2013. This month there in one diagnostic guideline and one public health guideline that impact upon primary care.
The Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel diagnostic guideline recommends that faecal calprotectin testing is made available as an option to help doctors distinguish between inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis, and non-inflammatory bowel diseases, such as irritable bowel syndrome. It is hoped that this test will help to reduce the number of people with irritable bowel syndrome having unnecessary invasive hospital investigations before their condition is diagnosed. Clinicians will need to check availability of this test with local pathology providers.
The Managing overweight and obesity among children and young people public health guideline makes recommendations on lifestyle weight management services for overweight and obese children and young people aged under 18. This guideline make several recommendations including raising awareness of lifestyle weight management programmes and formal referrals to such programmes.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
|« MTRAC Reviews - October 2013||Mefloquine and Neuropsychiatric reactions »|